Search

Now showing items 1-10 of 22

Resistance relationships between platinum and parp-inhibitors in ovarian cancer.

STORDAL, BRITTA KRISTINA (2012)

THE EMT-ACTIVATOR ZEB1 IS UNRELATED TO PLATINUM DRUG RESISTANCE IN OVARIAN CANCER BUT PREDICTIVE OF SURVIVAL

STORDAL, BRITTA KRISTINA (2014)

Current research into the cell biology of ovarian cancer: The DISCOVARY consortium and beyond

STORDAL, BRITTA KRISTINA (2013)

Molecular testing in oncology: Problems, pitfalls and progress.

FINN, STEPHEN; O'LEARY, JOHN (2014)

Collateral Sensitivity to Cisplatin in KB-8-5-11 Drug-resistant Cancer Cells.

STORDAL, BRITTA KRISTINA (2014)

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

SMYTH, PAUL; MARTIN, CARA; MCINERNEY, JAMIE KEVIN; ELBARUNI, SALAH AMRU; O'LEARY, JOHN; SALLEY, YVONNE; VENCKEN, SEBASTIAN; O'TOOLE, SHARON; AHERNE, SINEAD; SHEILS, ORLA; GALLAGHER, MICHAEL (2009)

Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.

MARTIN, CARA; O'LEARY, JOHN (2011)

Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy.

O'TOOLE, SHARON; PILKINGTON, LORETTO; MARTIN, CARA; O'LEARY, JOHN; KEEGAN, HELEN (2013)

Aspirin and P2Y<inf>12</inf> inhibition attenuate platelet-induced ovarian cancer cell invasion

SHEILS, ORLA; O'LEARY, JOHN; SPILLANE, CATHY (2015)

Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review.

STORDAL, BRITTA KRISTINA (2011)

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Resistance relationships between platinum and parp-inhibitors in ovarian cancer.

THE EMT-ACTIVATOR ZEB1 IS UNRELATED TO PLATINUM DRUG RESISTANCE IN OVARIAN CANCER BUT PREDICTIVE OF SURVIVAL

Current research into the cell biology of ovarian cancer: The DISCOVARY consortium and beyond

Molecular testing in oncology: Problems, pitfalls and progress.

Collateral Sensitivity to Cisplatin in KB-8-5-11 Drug-resistant Cancer Cells.

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.

Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy.

Aspirin and P2Y<inf>12</inf> inhibition attenuate platelet-induced ovarian cancer cell invasion

Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review.

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Advanced Search

Resistance relationships between platinum and parp-inhibitors in ovarian cancer.

THE EMT-ACTIVATOR ZEB1 IS UNRELATED TO PLATINUM DRUG RESISTANCE IN OVARIAN CANCER BUT PREDICTIVE OF SURVIVAL

Current research into the cell biology of ovarian cancer: The DISCOVARY consortium and beyond

Molecular testing in oncology: Problems, pitfalls and progress.

Collateral Sensitivity to Cisplatin in KB-8-5-11 Drug-resistant Cancer Cells.

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.

Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy.

Aspirin and P2Y<inf>12</inf> inhibition attenuate platelet-induced ovarian cancer cell invasion

Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review.